RA-ILD has worse outcomes than RA and is most likely in those with extra-articular RA manifestations and in those who are ...
Three out of four efzofitimod-treated diffuse SSc-ILD patients showed clinically important improvement based on the modified Rodnan Skin Score (mRSS) assessment at 12 weeks. Efzofitimod was generally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback